Prostatitis, benign prostatic hyperplasia, and prostate cancer: a bidirectional Mendelian randomization study and

Yi Wang1,2, Guihua Chen2, Deng Li2

  • 1Department of Urology, Affiliated Hospital of Nantong University, No.20 West Temple Road, Nantong, Jiangsu Province, 226001, China.

Biology Direct
|December 19, 2024
PubMed

Insights

Genetic susceptibility to prostatitis or benign prostatic hyperplasia (BPH) increases prostate cancer (PCa) risk. Mendelian randomization revealed causal links and three vicious circles driving disease progression, offering insights for drug development.

Area of Science:

  • Urology
  • Genetics
  • Epidemiology

Background:

  • Lack of authoritative guidelines on interrelationships between prostatitis, benign prostatic hyperplasia (BPH), and prostate cancer (PCa).
  • No consensus exists among published epidemiological studies or meta-analyses regarding these prostate conditions.

Purpose of the Study:

  • To clarify the causal relationships among prostatitis, BPH, and PCa using Mendelian randomization.
  • To provide clinical implications for patient populations affected by these prostate conditions.

Main Methods:

  • Employed bidirectional two-sample and mediator Mendelian randomization to investigate causal links.
  • Conducted comprehensive sensitivity analyses (phenotype scanning, heterogeneity, pleiotropy, leave-one-out, Steiger test) for result validation.

Main Results:

  • Confirmed genetic susceptibility to prostatitis or BPH causally increases PCa risk (P < 0.05).
  • Identified four mediator pathways (e.g., prostatitis-BPH-PCa) and three vicious circles (prostatitis-BPH, BPH-PCa, prostatitis-BPH-PCa).
  • These circles contribute to the progression from benign to malignant prostate diseases.

Conclusions:

  • Successfully elucidated the interrelationships among prostatitis, BPH, and PCa.
  • Provided significant clinical implications for patient management and decision-making.
  • Revealed three vicious circles offering novel avenues for drug development and therapeutic strategies.
Abstract